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FABRIKASI KERANGKA TULANG 3D BERLIANG BETA TRIKALSIUM 
FOSFAT BERSALUT POLI(VINIL ALKOHOL) DAN POLI(LAKTIK ASID) 
ABSTRAK 
 Kerangka β-TCP yang bersambungan liang telah dihasilkan dengan cara 
replika busa poliuretana. Kerangka tersebut kemudian disalut dengan PVA dan PLA 
untuk meningkatkan kekuatan mampatannya. Kajian di peringkat pertama adalah 
pengoptimuman rangkaian dalaman kerangka β-TCP (dengan pengurangan kecacatan) 
sebelum disalut dengan polimer bio. Kerangka yang terhasil daripada buburan β-TCP 
dan air dalam nisbah 10g:8ml dengan penambahan 2 wt. % PVA dan PEG, dan disinter 
pada 1250°C selama 2 jam mempunyai makro- dan mikroliang yang optimum. 
Kerangka optimum yang terhasil mempunyai keporosan sebanyak 95.3%, tanpa 
makroliang tersumbat dan mempunyai topang yang berketebalan sekata serta rekahan 
yang minimum. Dalam proses penyalutan polimer bio di kajian peringkat kedua, 
penyalutan dengan PVA berkepekatan tinggi menyebabkan makroliang tersumbat 
manakala penyalutan dengan PVA berkepekatan rendah menyebabkan topang di 
bahagian tengah sampel gagal disalut. PLA kemudian digunakan sebagai lapisan dwi-
salutan kepada sampel yang disalut oleh PVA berkepekatan rendah. Dari aspek 
mekanikal, kekuatan mampatan kerangka meningkat apabila berat peratusan polimer 
yang disalut bertambah. Peregangan polimer di antara retakan menunjukkan 
mekanisme titian retakan yang memperkuatkan kerangka β-TCP yang rapuh. 
Kerangka yang disalut dengan 3 wt. % PVA dan seterusnya dengan 5 wt. % PLA 
(V3_L5) mempunyai kekuatan mampatan tertinggi (83.7 kPa) tanpa sumbatan 
makroliang. Dari segi bioaktiviti, β-TCP mengambil masa 2 minggu untuk 
pembentukan apatit dalam SBF tetapi V3_L5 mengambil masa selama 4 minggu. Ini 
menunjukkan PLA yang hidrofobik melanjutkan masa pembentukan apatit. 
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FABRICATION OF 3D POROUS BETA-TRICALCIUM PHOSPHATE BONE 
SCAFFOLD COATED BY POLY(VINYL ALCOHOL) AND     
POLY(LACTIC ACID) 
ABSTRACT 
 The interconnected porous β-TCP scaffold was produced via polyurethane (PU) 
foam replica method. PVA and/or PLA were coated on the scaffold to enhance the 
compressive strength. The first part of this study was to optimise the internal 
architecture of β-TCP scaffold with minimal defect before biopolymer coating. 
Optimum macro- and microporosity in β-TCP scaffold were produced by slurry with 
ratio 10g:8ml of powder to water and addition of 2 wt. % of PVA and PEG and sintered 
at 1250°C for 2 hours. The optimum scaffold had 95.3% of porosity with unblock 
macropore, minimum crack and regular thickness of strut. In the second part, during 
biopolymer coating, single layer coating with higher PVA concentration had 
macropores blockage, while lower PVA concentration coating showed uncoated at 
interior of the scaffold. Bi-layer coating with PLA was to compensate the uncoated 
interior region in lower PVA concentration coated sample. In terms of mechanical 
property, compressive strength of the coated scaffold increased with the coated weight 
percentage of biopolymer. Polymer stretched at the crack opening showed crack 
bridging mechanism, which toughened the brittle β-TCP scaffold. Scaffold bi-layer 
coated with 3 wt. % of PVA and subsequently 5 wt. % PLA (V3_L5) had the highest 
compressive strength (83.7 kPa) with no macropore blocking by biopolymer. In terms 
of bioactivity, β-TCP without biopolymer coating took 2 weeks to form apatite but 
V3_L5 took 4 weeks after immersion in SBF. This showed that coating with 
hydrophobic PLA delayed the time of apatite formation. 
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  CHAPTER ONE 
INTRODUCTION 
1.1 Research Background 
Human body is susceptible to damage or deterioration due to aging, accidents 
or disease factors. Some losses such as the loss of limbs and teeth, organs like kidney 
or brain are permanent as our body is unable to regenerate it. So, necessity of lose 
organ replacement triggers the continuous advancement in biomedical area, such as 
tissue engineering. The main subject in this study is the replacement materials for the 
bone. Bone is one important organ in our body, which it plays important roles in critical 
functions in human physiology including protection, movement, support of other 
critical organs, blood production, blood pH regulation, mineral storage and 
homeostasis (Mohamed & Shamaz, 2015). 
Orthopaedic fracture of bone is very common and our bone is very unique with 
its self-healing ability, with modern medical treatment it can heal without much 
problem. However, when large bone portion was removed due to diseases or trauma, 
bone regeneration would be disturbed and it is far beyond the ability of self-healing 
leading to complication associated with delayed union or facture non-union (Gómez-
Barrena et al., 2015; Pilia et al., 2013; Jones & Hench, 2003). As a treatment to these 
bone defects, the alternative is to replace the bone loss portion with bone scaffold. 
Traditional tissue implantation (i.e. autographs, allographs, and xenographs) 
has been the source of bone grafting replacement. However, their limitations are donor 
site undersupply, high rejection rate, disease transfer, harvesting cost and postoperative 
morbidity. So, current approach is to replace biological material with synthetic 
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materials (Oryan et al., 2014; Keating & Mcqueen, 2001; Navarro et al., 2008). A 
synthetic bone scaffold has to be biocompatible, bioresorbable, porous with 
interconnected pores, having sufficient mechanical stability and bioactive in order to 
trigger cell response as well as assist in bone healing (Pilia et al., 2013). Engineering 
team combines the material selection and fabrication technology in scaffold 
construction to fulfil the requirements (Mohamed & Shamaz, 2015). 
Similarly, fabrication of a ceramic-polymer bone scaffold was embark to 
mimic the structure of natural human bone, which consists of interpenetrating of 
inorganic hydroxyapatite and biological collagen (Mohamed & Shamaz, 2015). 
However, challenges exist as to combine ceramic and polymer since processing 
temperature for these two materials are distinctly different. Hence polymer coated 
ceramic framework method has been suggested to overcome this shortcoming. Besides, 
polymer is a ductile material, the addition of polymer phase hence was intended to 
reduce the brittleness of β-TCP ceramic phase. Similar works showing the 
improvement of mechanical strength have been reported by Bang et al. (2013) of poly 
(ε-carpolactone) (PCL) coated α-TCP, Miao et al. (2007) of PLGA coated HA/TCP 
and Nie et al. (2012) of BCP multiply coated by HA/PLLA. 
Among fabrication techniques, polyurethane (PU) sponge replica method is the 
straightforward and simple method to produce a porous structure scaffold. Spongy 
architecture of the PU provides the replication template to produce an interconnected 
and macroporous ceramic scaffold (Mohamad-Yunos et al., 2008). Although trade-off 
between mechanical strength and porous structure existed, to combine with polymer 
phase, the polymer coating uses the distinct interconnected porous characteristic 
produced via this sponge replication method, to infiltrate into the ceramic framework 
to enhance the toughness of ceramic phase. 
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In terms of materials selection, hydroxyapatite (HA) resembles the chemical 
composition with inorganic phase of bone, and hence it is often the prime candidate of 
bone scaffold material (Dorozhkin, 2011b; Barakat et al., 2008). But HA has low 
bioresorption rate. A relatively resorbable beta-tricalcium phosphate (β-TCP) instead 
is a more promising material to construct a bone scaffold (Liu & Lun, 2012; Sohier et 
al., 2010). A resorbable implant is a better regeneration route to replace the substituted 
part with bone tissue in a slowly manner (Alves et al., 2010; Giannoudis et al., 2005). 
In addition, β-TCP with Ca/P ratio of 1.5 is within the range of human bone than pure 
HA (Ca/P ratio of human bone is 1.3 to 1.66, depending on the person’s age) (Horowitz 
et al., 2010). 
In the case of the polymer phase, poly(vinyl alcohol) (PVA) and poly(lactic 
acid) (PLA) are two examples of biocompatible and biodegradable polymers being 
developed in medicine and pharmaceutical application. PVA was reported to be elastic 
(Tamariz & Rios-ramírez, 2013; Asran et al., 2010) and its combination with ceramic 
scaffold significantly enhanced the scaffold mechanical strength (Song et al., 2011; 
Degirmenbasi et al., 2006). PLA was also reported having excellent mechanical 
property due to its crystallinity and hence being used in biomedical application 
(Davachi & Kaffashi, 2015; Pawar et al., 2014; Savioli-Lopes et al., 2012). 
1.2 Problem Statement 
Although HA resembles the mineral phase of human, β-TCP was used instead 
due to the relatively balanced resorption and bone regeneration rate (Liu & Lun, 2012). 
It is reported that a porous scaffold of total porosity 70-95% with interconnected pores 
of diameter ranging from 200-900µm is beneficial for bone growth and vascularisation 
(Asaad et al., 2016; Pilia et al., 2013). In this study, polyurethane (PU) sponge replica 
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method was employed to produce a β-TCP scaffold which has high porosity with 3 
dimensional interconnected porous structure. However, the porosity affects the 
mechanical properties of the scaffold, where the compressive strength decreases as the 
porosity increases. Therefore incorporation with ductile polymer was hypothesised to 
be able to enhance the toughness of β-TCP scaffold (Asaad et al., 2016; Kang et al., 
2011). 
In the first part of this study involving the bioceramic framework fabrication, 
the PU sponge replica method involves coating of the PU sponge with the β-TCP slurry 
and this was followed by burning out of the PU template through sintering. The 
properties of the β-TCP scaffold (i.e. strut appearance) were related to the condition of 
slurry and sintering profile (Monmaturapoj & Yatongchai, 2011; Mohamad-Yunos et 
al., 2008). Hence, sintering and slurry condition were studied to optimise the internal 
architecture (macro-, microporosity, total porosity and morphology of the strut) of the 
β-TCP scaffold. The β-TCP framework optimising is important to reduce as many 
defect point (i.e. crack) as possible before the work proceed to biopolymer coating in 
the second part. 
One approach to strengthen the mechanical strength of the porous scaffold is 
to coat with polymer layer (Asaad et al., 2016; Kang et al., 2011). In biopolymer 
coating, the biopolymer solution was not only coated on the strut surface but was made 
to fill the existing micropores in the bioceramic scaffold forming the interpenetrating 
network within the β-TCP framework (Mohamad-Yunos et al., 2008). The biopolymer 
phase also acts as a binder to hold the ceramic phase, which would bridge cracks during 
fracture subsequently increasing the scaffold toughness. 
As reported that the combination of ceramic scaffolds with PLA (Martínez-
Vázquez et al., 2014) and with PVA (Song et al., 2011) improved the mechanical strength 
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of the materials, hence in this study compressive strength of β-TCP scaffolds coated with 
these two biopolymers (single and bi-layer of PVA and PLA) were compared. Adding 
that synthetic biopolymer was reported as not bioactive (Asaad et al., 2016; Boccaccini et 
al., 2013), the bioactivity of hydrophilic PVA and/or the hydrophobic PLA coating on the 
bioactive bioceramic were being investigated via immersion in SBF for a period of time. 
1.3 Research Objective 
The aim of this study is to develop bioceramic-biopolymer scaffold made up 
of β-TCP, PVA and PLA, which leads to the following objectives: 
i. To fabricate β-TCP scaffold by polyurethane sponge replica method. 
ii. To optimise the internal architecture of β-TCP scaffold through the effect of 
sintering condition, ratio of β-TCP to water and addition of binder. 
iii. To improve the compressive strength of β-TCP scaffold by biopolymer coating. 
iv. To evaluate the in vitro bioactivity of β-TCP scaffold before and after biopolymer 
coating. 
1.4 Scope of Research 
This study was divided into three stages: started from the optimising fabrication 
study of β-TCP scaffold, followed by the PVA and/or PLA coating, and lastly 
bioactivity evaluation of the scaffold before and after polymer coating. Internal 
architecture of β-TCP scaffold produced in first stage is important to have minimum 
undesired defect before proceeded to next stage. Also, fabrication process determines 
the microporosity structure of the β-TCP matrix, which enable the interpenetration of 
polymer and β-TCP phase. Flow chart of this study is shown in Figure 1.1. 
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Figure 1.1 Flowchart of the overall research work. 
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  CHAPTER TWO 
LITERATURE REVIEW 
2.1 Introduction 
This research work focuses on fabrication of synthetic bone scaffold as the 
alternative to tissue transplantation for orthopaedic injury treatment. In order to 
produce a scaffold biomimetic to bone, this chapter starts with a brief insight of hard 
tissue mineralisation, bone structure and remodeling process. It is then followed by 
bone scaffold for orthopaedic. After understanding the requirements of an ideal bone 
scaffold, materials selection and fabrication techniques of synthetic bone scaffold, 
particularly bioceramic and biopolymer and their combination are discussed. Lastly, 
β-TCP scaffold coated with PVA and PLA are presented and discussed. 
2.2 Hard Tissue Mineralisation 
Bone, dentin and dental enamel are the hard tissues existed in human body 
(Brien, 2011). Dentin and enamel are the substances that constitute the inner and outer 
layer of the teeth while bone is a hard endoskeletal connective tissue composed of 
inorganic mineral HA. The similarity between these hard tissues is they are made from 
natural calcium phosphate ceramics (Dorozhkin, 2011b). 
Basic unit of bone tissue is a mineralised collagen fibril (refer to Figure 2.1). 
Bone tissues are produced by a series of natural biomineralisation process, which is 
also known as calcification, indicating that accumulation or precipitation of calcium 
to form bone (Alves et al., 2010). Collagen fibrils are formed by self-assembly of 
collagen triple helices, it acts as the template for the nucleation of HA nanocrystals on 
